谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Cabozantinib (CABO) Tolerance and Efficacy for Patients with Advanced Hepatocellular Carcinoma (HCC) after Failure of Sorafenib (SOR) in a French Population: CLERANCE, a Phase 4 Trial.

Philippe Merle,Mohamed Bouattour,Jean-Frederic Blanc,Jean-Marie Peron,Marilyne Debette-Gratien,Pierre Nahon,Eric Nguyen-Khac,Jean Marc Phelip,Eric Assenat,Vincent Bourgeois,Carine Richou,Alexandra Heurgue,Jean-Pierre Bronowicki,Isabelle Ollivier-Hourmand,Thomas Uguen,Stephane Cattan,Sylvie Thevenon,Camille Boucheny,Pierre Pradat

Journal of Clinical Oncology（2023）

引用 0|浏览11
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要